152 related articles for article (PubMed ID: 25631326)
1. Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells.
Han X; Sheng X; Jones HM; Jackson AL; Kilgore J; Stine JE; Schointuch MN; Zhou C; Bae-Jump VL
J Hematol Oncol; 2015 Jan; 8():2. PubMed ID: 25631326
[TBL] [Abstract][Full Text] [Related]
2. Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.
Manerba M; Vettraino M; Fiume L; Di Stefano G; Sartini A; Giacomini E; Buonfiglio R; Roberti M; Recanatini M
ChemMedChem; 2012 Feb; 7(2):311-7. PubMed ID: 22052811
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic Cancer.
Moir JAG; Long A; Haugk B; French JJ; Charnley RM; Manas DM; Wedge SR; Mann J; Robinson SM; White SA
Pancreas; 2020; 49(10):1364-1371. PubMed ID: 33122526
[TBL] [Abstract][Full Text] [Related]
4. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
[TBL] [Abstract][Full Text] [Related]
5. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
Manerba M; Di Ianni L; Fiume L; Roberti M; Recanatini M; Di Stefano G
Eur J Pharm Sci; 2015 Jul; 74():95-102. PubMed ID: 25930121
[TBL] [Abstract][Full Text] [Related]
6. Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.
Vettraino M; Manerba M; Govoni M; Di Stefano G
Anticancer Drugs; 2013 Sep; 24(8):862-70. PubMed ID: 23797802
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A.
Rupiani S; Guidotti L; Manerba M; Di Ianni L; Giacomini E; Falchi F; Di Stefano G; Roberti M; Recanatini M
Org Biomol Chem; 2016 Nov; 14(46):10981-10987. PubMed ID: 27827510
[TBL] [Abstract][Full Text] [Related]
8. Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.
Fiume L; Manerba M; Vettraino M; Di Stefano G
Pharmacology; 2010; 86(3):157-62. PubMed ID: 20699632
[TBL] [Abstract][Full Text] [Related]
9. Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells.
Fiume L; Vettraino M; Carnicelli D; Arfilli V; Di Stefano G; Brigotti M
Biochem Biophys Res Commun; 2013 Jan; 430(2):466-9. PubMed ID: 23237800
[TBL] [Abstract][Full Text] [Related]
10. Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.
Han J; Zhang L; Guo H; Wysham WZ; Roque DR; Willson AK; Sheng X; Zhou C; Bae-Jump VL
Gynecol Oncol; 2015 Sep; 138(3):668-75. PubMed ID: 26135947
[TBL] [Abstract][Full Text] [Related]
11. Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma.
Yeung C; Gibson AE; Issaq SH; Oshima N; Baumgart JT; Edessa LD; Rai G; Urban DJ; Johnson MS; Benavides GA; Squadrito GL; Yohe ME; Lei H; Eldridge S; Hamre J; Dowdy T; Ruiz-Rodado V; Lita A; Mendoza A; Shern JF; Larion M; Helman LJ; Stott GM; Krishna MC; Hall MD; Darley-Usmar V; Neckers LM; Heske CM
Cancer Res; 2019 Oct; 79(19):5060-5073. PubMed ID: 31431459
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate dehydrogenase complex and lactate dehydrogenase are targets for therapy of acute liver failure.
Ferriero R; Nusco E; De Cegli R; Carissimo A; Manco G; Brunetti-Pierri N
J Hepatol; 2018 Aug; 69(2):325-335. PubMed ID: 29580866
[TBL] [Abstract][Full Text] [Related]
13. Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells.
Manerba M; Di Ianni L; Govoni M; Roberti M; Recanatini M; Di Stefano G
Eur J Pharm Sci; 2017 Jan; 96():37-44. PubMed ID: 27622920
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer.
Wang Z; Wang D; Han S; Wang N; Mo F; Loo TY; Shen J; Huang H; Chen J
PLoS One; 2013; 8(2):e56631. PubMed ID: 23457597
[TBL] [Abstract][Full Text] [Related]
15. Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment.
Balboni A; Govoni M; Rossi V; Roberti M; Cavalli A; Di Stefano G; Manerba M
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129760. PubMed ID: 33035602
[TBL] [Abstract][Full Text] [Related]
16. Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.
Liu X; Yang Z; Chen Z; Chen R; Zhao D; Zhou Y; Qiao L
Oncol Rep; 2015 Jan; 33(1):157-62. PubMed ID: 25394466
[TBL] [Abstract][Full Text] [Related]
17. Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells.
Wendt EHU; Schoenrogge M; Vollmar B; Zechner D
Anticancer Res; 2020 Jan; 40(1):153-160. PubMed ID: 31892563
[TBL] [Abstract][Full Text] [Related]
18. Symmetric molecules with 1,4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-A.
Altamimi AS; Alafeefy AM; Balode A; Vozny I; Pustenko A; El Shikh ME; Alasmary FAS; Abdel-Gawad SA; Žalubovskis R
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):147-150. PubMed ID: 29199484
[TBL] [Abstract][Full Text] [Related]
19. Real-time monitoring of cancer cell metabolism and effects of an anticancer agent using 2D in-cell NMR spectroscopy.
Wen H; An YJ; Xu WJ; Kang KW; Park S
Angew Chem Int Ed Engl; 2015 Apr; 54(18):5374-7. PubMed ID: 25752301
[TBL] [Abstract][Full Text] [Related]
20. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
